Repligen (RGEN) Market Cap 1987–2026

As of November 13, 2026, Repligen had a market cap of $9.512 billion, which increased by 0.76% compared to the previous trading day. Market capitalization, often referred to as market cap, represents the total value of a company's outstanding shares on the stock market and is a common measure of its overall size and valuation.

Data updated: Nov 13, 2026, 4:00 PM ET
Repligen logo

Repligen Corp. (RGEN)

🌍 United States 📈 NASDAQ 🏭 Health Care 🏢 Life Sciences Tools & Services
Latest Market Cap
$9.512B ▲ 0.76%
Start of 2026
$9.224B ▲ 3.12%
1 Year Ago
$8.475B ▲ 12.24%
All-Time High
$17.825B ▼ 46.64%


Loading data...


Note: Each point on the chart represents the market capitalization at the end of the trading day.
Source: Data compiled from EDGAR filings, Bloomberg and Yahoo Finance.

📈 Repligen Market Cap History by Year and Month

Repligen Market Cap History by Year and Month
Year / MonthMarket Cap% Change
2026$9.512B▲ 3.12%
$9.512B▼ 5.16%
$10.03B▼ 7.56%
$10.85B▲ 6.27%
$10.21B▲ 28.31%
$7.957B▲ 3.40%
$7.695B▲ 10.05%
$6.992B▲ 4.91%
$6.665B▲ 0.42%
$6.637B▼ 8.47%
$7.251B▼ 13.76%
$8.408B▼ 8.85%
2025$9.224B▲ 14.25%
2024$8.074B▼ 19.57%
2023$10.038B▲ 6.79%
2022$9.4B▼ 35.84%
All market cap values reflect closing prices for the period shown.

📊 Repligen Market Cap and Other Industry Peers

Below are selected companies for comparison based on industry, sub-industry, and sector:

  1. $49.05B
  2. $45.23B
  3. $43.69B
  4. $34.59B
  5. $31.47B
  6. $29.07B
  7. $18.24B
  8. $17.23B
  9. $16.18B
  10. $13.03B
  11. $11.43B
  12. $10.53B
  13. $10.3B
  14. $9.85B
  15. $9.51B
  16. $9.41B
  17. $7.65B
  18. $4.74B
  19. $1.95B
  20. $1.91B


Data reflect the most recent market capitalization values available.

Note: Market capitalization figures are based on available sources and may differ slightly from actual values, particularly for historical data.